These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 18660702)

  • 1. Activation of the innate immune system by the endogenous ligand hyaluronan.
    Shirali AC; Goldstein DR
    Curr Opin Organ Transplant; 2008 Feb; 13(1):20-5. PubMed ID: 18660702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Innate alloimmunity: history and current knowledge.
    Land W
    Exp Clin Transplant; 2007 Jun; 5(1):575-84. PubMed ID: 17617046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of Toll-like receptor-driven innate immunity in thoracic organ transplantation.
    Goldstein DR; Palmer SM
    J Heart Lung Transplant; 2005 Nov; 24(11):1721-9. PubMed ID: 16297771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toll-like receptors and other links between innate and acquired alloimmunity.
    Goldstein DR
    Curr Opin Immunol; 2004 Oct; 16(5):538-44. PubMed ID: 15341996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Roles of toll-like receptors signaling in organ transplantation.
    Li T; Chen G; Zhang Z
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Dec; 36(12):1125-33. PubMed ID: 22246357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toll like receptors and acute allograft rejection.
    Goldstein DR
    Transpl Immunol; 2006 Dec; 17(1):11-5. PubMed ID: 17157206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple roles of Toll-like receptor signaling in atherosclerosis.
    Björkbacka H
    Curr Opin Lipidol; 2006 Oct; 17(5):527-33. PubMed ID: 16960501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of innate and adaptive immunity on rejection and tolerance.
    Kim IK; Bedi DS; Denecke C; Ge X; Tullius SG
    Transplantation; 2008 Oct; 86(7):889-94. PubMed ID: 18852649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tracking the toll of kidney disease.
    Shirali AC; Goldstein DR
    J Am Soc Nephrol; 2008 Aug; 19(8):1444-50. PubMed ID: 18579638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging science, emerging ethical issues: who should fund innate alloimmunity-suppressing drugs?
    Land WG; Gutmann T; Daar AS
    Acta Chir Belg; 2008; 108(1):73-82. PubMed ID: 18411578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of Toll-like receptors in non-infectious lung injury.
    Jiang D; Liang J; Li Y; Noble PW
    Cell Res; 2006 Aug; 16(8):693-701. PubMed ID: 16894359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toll-like receptors and graft rejection.
    Liu G; Wu Y; Gong S; Zhao Y
    Transpl Immunol; 2006 Jun; 16(1):25-31. PubMed ID: 16701173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Innate immunity-mediated allograft rejection and strategies to prevent it.
    Land WG
    Transplant Proc; 2007 Apr; 39(3):667-72. PubMed ID: 17445569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Innate immunity and its role in type 1 diabetes.
    Zipris D
    Curr Opin Endocrinol Diabetes Obes; 2008 Aug; 15(4):326-31. PubMed ID: 18594272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toll-like receptor signaling pathways and the evidence linking toll-like receptor signaling to cardiac ischemia/reperfusion injury.
    Wang Y; Abarbanell AM; Herrmann JL; Weil BR; Poynter J; Manukyan MC; Crisostomo PR; Meldrum DR
    Shock; 2010 Dec; 34(6):548-57. PubMed ID: 20458266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emerging evidence that molecules expressed by mammalian tissue grafts are recognized by the innate immune system.
    Fox-Marsh A; Harrison LC
    J Leukoc Biol; 2002 Mar; 71(3):401-9. PubMed ID: 11867677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Innate immunity in transplant tolerance and rejection.
    Murphy SP; Porrett PM; Turka LA
    Immunol Rev; 2011 May; 241(1):39-48. PubMed ID: 21488888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Sterile inflammatory response to ischemia-reperfusion injury: immediate and long term consequences on graft function].
    Thaunat O
    Bull Acad Natl Med; 2011; 195(4-5):847-59; discussion 859. PubMed ID: 22375356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyaluronan, CD44, and cyclooxygenase-2 in colon cancer.
    Misra S; Hascall VC; Berger FG; Markwald RR; Ghatak S
    Connect Tissue Res; 2008; 49(3):219-24. PubMed ID: 18661347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CARD9 signaling in the innate immune response.
    Ruland J
    Ann N Y Acad Sci; 2008 Nov; 1143():35-44. PubMed ID: 19076343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.